Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ICT-107 |
Synonyms | |
Therapy Description |
ICT-107 is a vaccine consisting of autologous dendritic cells pulsed with tumor associated antigen peptides MAGEA1, ERBB2 (HER2), AIM2, RANBP2 (TRP2), PMEL (gp100), and IL13RA2, which has potential antitumor activity (PMID: 31320597). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ICT-107 | ICT107|ICT 107 | ICT-107 is a vaccine consisting of autologous dendritic cells pulsed with tumor associated antigen peptides MAGEA1, ERBB2 (HER2), AIM2, RANBP2 (TRP2), PMEL (gp100), and IL13RA2, which has potential antitumor activity (PMID: 31320597). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|